Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 65 Rituximab 62 fludarabine 40 Etoposide 25 Lenalidomide 19 fludarabine phosphate 17 Immunotherapy, Adoptive 17 Doxorubicin 17 Cytarabine 17 Vincristine 15 Magnetic Resonance Spectroscopy 14 Prednisone 13 pembrolizumab 11 Specimen Handling 11 Dexamethasone 10 CT-P10 10 Melphalan 9 Carmustine 9 Carboplatin 9 Bortezomib 9 Bendamustine Hydrochloride 9 obinutuzumab 8 ibrutinib 8 Mycophenolic Acid 8 Biopsy 8 Radiotherapy 7 Ifosfamide 7 polatuzumab vedotin 6 Whole-Body Irradiation 6 Methotrexate 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, B-Cell × Tubercidin × Clear all

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡